Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational study

[1]  S. Patarnello,et al.  A real-time integrated framework to support clinical decision making for covid-19 patients , 2022, Computer Methods and Programs in Biomedicine.

[2]  Alan D. Lopez,et al.  Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis , 2022, The Lancet.

[3]  F. Segala,et al.  Cefiderocol for Severe Carbapenem-Resistant A. baumannii Pneumonia: Towards the Comprehension of Its Place in Therapy , 2021, Antibiotics.

[4]  D. MacFadden,et al.  Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression , 2021, Clinical Microbiology and Infection.

[5]  F. Segala,et al.  Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review , 2021, Viruses.

[6]  T. Greene,et al.  Experiences of frontline healthcare workers and their views about support during COVID-19 and previous pandemics: a systematic review and qualitative meta-synthesis , 2021, BMC Health Services Research.

[7]  M. Antonelli,et al.  Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis , 2021, Critical Care.

[8]  M. Antonelli,et al.  Hospital-Acquired Infections in Critically Ill Patients With COVID-19 , 2021, Chest.

[9]  J. Bello-López,et al.  Clonal dispersion of Acinetobacter baumannii in an intensive care unit designed to patients COVID-19. , 2021, Journal of infection in developing countries.

[10]  D. MacFadden,et al.  Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis , 2021, Clinical Microbiology and Infection.

[11]  G. Innes,et al.  Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions — New Jersey, February–July 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[12]  L. Wee,et al.  Unintended consequences of infection prevention and control measures during COVID-19 pandemic , 2020, American Journal of Infection Control.

[13]  M. M. van der Eerden,et al.  Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline , 2020, Clinical Microbiology and Infection.

[14]  M. Nishimura,et al.  Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations , 2020, The Lancet Respiratory Medicine.

[15]  Antimicrobial resistance in the EU/EEA (EARS-Net) , 2020 .

[16]  S. Harbarth,et al.  Methicillin-resistant Staphylococcus aureus , 2018, Nature Reviews Disease Primers.

[17]  M. Ouellette,et al.  Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. , 2017, The Lancet. Infectious diseases.

[18]  R. Mendes.  R: The R Project for Statistical Computing , 2016 .

[19]  R. Weinstein,et al.  Acinetobacter infection. , 2008, The New England journal of medicine.

[20]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.